Chicago Equity Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Chicago Equity Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-23,230	Closed	-$2.12M	–	834
2017 Q4	$2.12M	Sell	23,230 -7,010	-23%	-$583K	0.06%	354
2017 Q3	$2.3M	Buy	30,240 +1,760	+6%	+$133K	0.07%	344
2017 Q2	$2.14M	Sell	28,480 -485	-2%	-$33.6K	0.06%	359
2017 Q1	$1.89M	Sell	28,965 -13,930	-32%	-$820K	0.05%	338
2016 Q4	$2.36M	Sell	42,895 -6,590	-13%	-$362K	0.06%	301
2016 Q3	$2.8M	Buy	49,485 +20,065	+68%	+$984K	0.08%	243
2016 Q2	$1.23M	Buy	29,420 +10,950	+59%	+$504K	0.04%	363
2016 Q1	$790K	Buy	+18,470	New	+$780K	0.02%	394

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chicago Equity Partners's PRAH Position: Q1 2018 in Review

Chicago Equity Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2018, closing a stake of 23,230 shares — an estimated $2.12M sold.

Chicago Equity Partners first reported a position in PRAH in Q1 2016 and held it in 8 quarters. The position peaked at $2.8M in Q3 2016. 278 funds tracked by Wall St. Rank hold PRAH as of Q1 2018.

Chicago Equity Partners reported no remaining PRA Health Sciences, Inc. position as of Q1 2018 after selling out during the quarter.
Chicago Equity Partners sold 23,230 PRA Health Sciences, Inc. shares in Q1 2018, an estimated $2.12M.
Chicago Equity Partners first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 8 quarters.
Chicago Equity Partners's PRA Health Sciences, Inc. position peaked at $2.8M in Q3 2016.
278 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2018.

Based on Chicago Equity Partners's 13F filing for Q1 2018, filed 7 May 2018.